Leu Val Arg Phe - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

64816-14-4

L-Argininamide,D-Valyl-L-Leucyl-N-(4-nitroPhenyl)-;
D-Val-Leu-Arg-p-nitroanilide;
D-Valyl-L-Leucyl-L-Arginine p-nitroanilide

L-Argininamide,L-alanyl-L-prolyl-L-Leucyl-L-serylglycyl-L-Phenylalanyl-L-tyrosylglycyl-L-Valyl-;
LocustatachykininII;
Lom-TK II

L-Leucinamide,L-Leucyl-L-Valyl-L-prolyl-L-Phenylalanyl-L-Arginyl-L-prolyl-L-Arginyl-;
Pea-PK 3;
Pyrokinin 3;
Pyrokinin 3 (Periplaneta americana)

L-Phenylalaninamide,L-alanyl-L-Valyl-L-prolylglycyl-L-Valyl-L-Leucyl-L-Arginyl- (9CI);
122: PN:WO0131005 SEQID: 122 claimed protein;
3: PN: WO0138533 SEQID: 79 claimedprotein;
AF 3;
AF 3 (peptide)

L-NorLeucinamide,L-Arginyl-L-Valyl-L-Leucyl-y(CH2-NH)-L-Phenylalanyl-L-a-glutamyl-L-alanyl- (9CI);
L-NorLeucinamide,N-[2-[(N-L-Arginyl-L-Valyl)amino]-4-methylpentyl]-L-Phenylalanyl-L-a-glutamyl-L-alanyl-, (S)-;
N 1270

L-Phenylalaninamide,glycyl-L-a-aspartyl-L-Valyl-L-prolylglycyl-L-Valyl-L-Leucyl-L-Arginyl-(9CI);
123:PN: WO0131005 SEQID: 123 claimed protein;
8: PN: WO0138533 SEQID: 84 claimedprotein;
AF 4;
AF 4 (peptide)

L-Argininamide,L-alanyl-L-prolyl-L-seryl-L-Leucylglycyl-L-Phenylalanyl-L-histidylglycyl-L-Valyl-;
LocustatachykininIV;
Lom-TK IV

L-Phenylalaninamide,L-Valyl-L-prolyl-L-asparaginyl-L-Leucyl-L-prolyl-L-glutaminyl-L-Arginyl-;
NeuropeptideNPVF-amide;
Neuropeptide VF;
Rat RFRP-3

L-IsoLeucinamide,L-Leucyl-L-seryl-L-seryl-L-Phenylalanyl-L-Valyl-L-Arginyl- (9CI);
16: PN:WO0114883 SEQID: 28 claimed protein

L-Valine,L-Phenylalanyl-L-Leucyl-L-tryptophylglycyl-L-prolyl-L-Arginyl-L-alanyl-L-Leucyl-;
L-Valine,N-[N-[N-[N2-[1-[N-[N-(N-L-Phenylalanyl-L-Leucyl)-L-tryptophyl]glycyl]-L-prolyl]-L-Arginyl]-L-alanyl]-L-Leucyl]-;
11: PN: WO0049041 SEQID: 14 claimed sequence;
11: PN: WO0050589 SEQID: 11unclaimed sequence;
11: PN: WO2008019018 SEQID: 9 unclaimed sequence;
12: PN:US6291430 SEQID: 48 unclaimed sequence;
12: PN: WO0006598 SEQID: 13 unclaimedsequence;
12: PN: WO0127291 SEQID: 13 unclaimed sequence;
1379: PN:WO2006091734 PAGE: 74 claimed sequence;
13: PN: US6245525 SEQID: 7 unclaimedsequence;
140: PN: WO03008537 SEQID: 164 claimed sequence;
14: PN: US20040033541SEQID: 14 unclaimed sequence;
14: PN: WO0020445 SEQID: 4 unclaimed sequence;
14: PN: WO0129220 SEQID: 12 unclaimed sequence;
14: PN: WO2004052917 PAGE: 174claimed sequence;
15: PN: WO0123577 SEQID: 13 claimed sequence;
16: PN:WO2006082391 PAGE: 47 unclaimed sequence;
17: PN: US20050048646 TABLE: 1unclaimed sequence;
17: PN: WO2005115447 SEQID: 13 unclaimed sequence;
181: PN:WO0178655 SEQID: 34 claimed sequence;
193: PN: WO2007

腺苷酸环化酶激活肽-38(抗原)

H-HIS-SER-ASP-GLY-ILE-Phe-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-ALA-Val-LYS-LYS-TYR-Leu-ALA-AL;
H-HIS-SER-ASP-GLY-ILE-Phe-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-ALA-Val-LYS-LYS-TYR-Leu-ALA-ALA-Val-Leu-GLY-LYS-Arg-TYR-LYS-GLN-Arg-Val-LYS-ASN-LYS-NH2;
HIS-SER-ASP-GLY-ILE-Phe-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-ALA-Val-LYS-LYS-TYR-Leu-ALA-ALA-Val-Leu-GLY-LYS-Arg-TYR-LYS-GLN-Arg-Val-LYS-ASN-LYS-NH2;
HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2;
ADENYLATE CYCLASE ACTIVATING PEPTIDE-38;
ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38;
PACAP (1-38), AMIDE, HUMAN, OVINE, RAT;
PACAP (1-38), HUMAN, OVINE, RAT;
PACAP (1-38) (HUMAN, SHEEP, RAT)

无

HIS-ALA-ASP-ALA-Val-Phe-THR-ALA-ALA-TYR-ALA-Arg-Leu-Arg-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-Leu-ALA-ALA-;
[ALA2,8,9,11,19,22,24,25,27,28]-VIP;
HIS-ALA-ASP-ALA-Val-Phe-THR-ALA-ALA-TYR-ALA-Arg-Leu-Arg-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-Leu-ALA-ALA-ILE-ALA-ALA-NH2

H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH

H-ASP-ALA-GLU-Phe-Arg-HIS-ASP-SER-GLY-TYR-GLU-Val-HIS-HIS-GLN-LYS-Leu-Val-Phe-Phe-ALA-GLU-ASP-Val-GL;
PREDOMINANT AMYLOID B-PROTEIN FRAGMENT;
ASP-ALA-GLU-Phe-Arg-HIS-ASP-SER-GLY-TYR-GLU-Val-HIS-HIS-GLN-LYS-Leu-Val-Phe-Phe-ALA-GLU-ASP-Val-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-Leu-MET-Val-GLY-GLY-Val-Val-ILE-ALA;
ASP-ALA-GLU-Phe-GLY-HIS-ASP-SER-GLY-Phe-GLU-Val-Arg-HIS-GLN-LYS-Leu-Val-Phe-Phe-ALA-GLU-ASP-Val-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-Leu-MET-Val-GLY-GLY-Val-Val-ILE-ALA;
BAP 1-42;
BETA-AMYLOID, SODIUM SALT;
BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT;
BETA-AMYLOID PEPTIDE (1-40), RAT;
BETA-AMYLOID PEPTIDE (1-42), RAT

无

ASN-Arg-Val-TYR-Val-HIS-PRO-Phe-ASN-Leu

ASN-Arg-Val-TYR-Val-HIS-PRO-Phe-ASN-Leu;
ANTI-COAGULANT ENZYME;
ANGIOTENSIN I (SALMON);
ANGIOTENSIN I;
ANGIOTENSIN I (BULLFROG) (Val5, ASN8);
(ASN1,Val5,ASN9)-ANGIOTENSIN I;
(ASN1,Val5,ASN9) ANGIOTENSIN I SALMON;
ASN-Arg-Val-TYR-Val-HIS-PRO-Phe-ASN-Leu;
H-ASN-Arg-Val-TYR-Val-HIS-PRO-Phe-ASN-Leu-OH

Leu-Val-LYS-PRO-Arg-THR-SER-Arg-THR-GLY-PRO-GLY-ALA-TRP-GLN-GLY-GLY-Arg-Arg-LYS-Phe-Arg-Arg-GLN-Arg-;
APELIN-36, MOUSE, RAT;
APELIN-36 (RAT, MOUSE);
Leu-Val-LYS-PRO-Arg-THR-SER-Arg-THR-GLY-PRO-GLY-ALA-TRP-GLN-GLY-GLY-Arg-Arg-LYS-Phe-Arg-Arg-GLN-Arg-PRO-Arg-Leu-SER-HIS-LYS-GLY-PRO-MET-PRO-Phe;
Leu-Val-LYS-PRO-Arg-THR-SER-Arg-THR-GLY-PRO-GLY-ALA-TRP-GLN-GLY-GLY-Arg-Arg-LYS-Phe-Arg-Arg-GLN-Arg-PRO-Arg-Leu-SER-HIS-LYS-GLY-PRO-MET-PRO-Phe

神经储钙蛋白基质

ASP-Leu-ASP-Val-PRO-ILE-PRO-GLY-Arg-Phe-ASP-Arg-Arg-Val-SER-Val-ALA-ALA-GLU;
ASP-Leu-ASP-Val-PRO-ILE-PRO-GLY-Arg-Phe-ASP-Arg-Arg-Val-SER-Val-ALA-ALA-GLU;
DLDVPIPGRFDRRVSVAAE;
CALCINEURIN (PP2B) SUBSTRATE [DLDVPIPGRFDRRVSSVAAE], NON-PHOSPHORYLATED;
CALCINEURIN SUBSTRATE;
H-ASP-Leu-ASP-Val-PRO-ILE-PRO-GLY-Arg-Phe-ASP-Arg-Arg-Val-SER-Val-ALA-ALA-GLU-OH;
[ALA-97]-RII (81-99);
Calcineurin (PP2B) Substrate [DLDVPIPGRFDRRVSVAAE], Non-Phosphorylated

(DES-OCTANOYL)-GHRELIN (HUMAN)

H-GLY-SER-SER-Phe-Leu-SER-PRO-GLU-HIS-GLN-Arg-Val-GLN-GLN-Arg-LYS-GLU-SER-LYS-LYS-PRO-PRO-ALA-LYS-LE;
GSSFLSPEHQRVQQRKESKKPPAKLQPR;
GLY-SER-SER-Phe-Leu-SER-PRO-GLU-HIS-GLN-Arg-Val-GLN-GLN-Arg-LYS-GLU-SER-LYS-LYS-PRO-PRO-ALA-LYS-Leu-GLN-PRO-Arg;
H-GLY-SER-SER-Phe-Leu-SER-PRO-GLU-HIS-GLN-Arg-Val-GLN-GLN-Arg-LYS-GLU-SER-LYS-LYS-PRO-PRO-ALA-LYS-Leu-GLN-PRO-Arg-OH;
(DES-OCTANOYL)-GHRELIN (HUMAN);
H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH;
M.W. 3244.51 C141H235N47O41

PACAP (6-38), HUMAN, OVINE, RAT

H-Phe-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-ALA-Val-LYS-LYS-TYR-Leu-ALA-ALA-Val-Leu-GLY-LYS-AR;
FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2;
HIS-SER-ASP-GLY-ILE-Phe-THR-AP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-ALA-Val-LYS-LYS-TYR-Leu-ALA-ALA-Val-Leu-GLY-LYS-Arg-TYR-LYS-GLN-Arg-Val-LYS-ASN-LYS-NH2;
H-Phe-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-ALA-Val-LYS-LYS-TYR-Leu-ALA-ALA-Val-Leu-GLY-LYS-Arg-TYR-LYS-GLN-Arg-Val-LYS-ASN-LYS-NH2;
Phe-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-ALA-Val-LYS-LYS-TYR-Leu-ALA-ALA-Val-Leu-GLY-LYS-Arg-TYR-LYS-GLN-Arg-Val-LYS-ASN-LYS-NH2;
PITUITARY ADENYLATE ACTIVATING POLYPEPTIDE (6-38) (HUMAN, OVINE, RAT);
PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (6-38), HUMAN, OVINE, RAT;
PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38 (6-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT);
PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE (6-38) AMIDE (HUMAN, OVINE, RAT)

(D-Phe12,Leu14)-BOMBESIN

PYR-GLN-Arg-Leu-GLY-ASN-GLN-TRP-ALA-Val-GLY-D-Phe-Leu-Leu-NH2;
(D-Phe12,Leu14)-BOMBESIN;
GLP-GLN-Arg-Leu-GLY-ASN-GLN-TRP-ALA-Val-GLY-DPhe-Leu-Leu-NH2;
PGLU-GLN-Arg-Leu-GLY-ASN-GLN-TRP-ALA-Val-GLY-D-Phe-Leu-Leu-NH2;
PYR-QRLGNQWAVGFLL-NH2;
PYR-GLN-Arg-Leu-GLY-ASN-GLN-TRP-ALA-Val-GLY-D-Phe-Leu-Leu-NH2;
bombesin, Phe(12), Leu(14)-

PEPTIDE F (22-34) (BOVINE, OVINE)

H-GLY-GLY-GLU-Val-Leu-GLY-LYS-Arg-TYR-GLY-GLY-Phe-MET-OH;
GLY-GLY-GLU-Val-Leu-GLY-LYS-Arg-TYR-GLY-GLY-Phe-MET;
GLY-GLY-Leu-Val-Leu-GLY-Leu-Arg-TYR-GLY-Phe-MET;
H-GLY-GLY-GLU-Val-Leu-GLY-LYS-Arg-TYR-GLY-GLY-Phe-MET-OH;
PRE-PROENKEPHALIN (128-140) BOVINE;
PREPROENKEPHALIN (128-140) (BOVINE, OVINE);
PREPRO-ENKEPHALIN A (125-137) (BOVINE, OVINE);
PREPRO-ENKEPHALIN, FRAGMENT 128-140;
PEPTIDE F (22-34) (BOVINE, OVINE)

C61H95N17O17S

详情

供应商

化工产品